144 related articles for article (PubMed ID: 28688199)
1. Differential expression of PARK2 splice isoforms in an in vitro model of dopaminergic-like neurons exposed to toxic insults mimicking Parkinson's disease.
La Cognata V; Maugeri G; D'Amico AG; Saccone S; Federico C; Cavallaro S; D'Agata V
J Cell Biochem; 2018 Jan; 119(1):1062-1073. PubMed ID: 28688199
[TBL] [Abstract][Full Text] [Related]
2. Formation of parkin aggregates and enhanced PINK1 accumulation during the pathogenesis of Parkinson's disease.
Um JW; Park HJ; Song J; Jeon I; Lee G; Lee PH; Chung KC
Biochem Biophys Res Commun; 2010 Mar; 393(4):824-8. PubMed ID: 20171192
[TBL] [Abstract][Full Text] [Related]
3. Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research.
Cheung YT; Lau WK; Yu MS; Lai CS; Yeung SC; So KF; Chang RC
Neurotoxicology; 2009 Jan; 30(1):127-35. PubMed ID: 19056420
[TBL] [Abstract][Full Text] [Related]
4. miR-103a-3p regulates mitophagy in Parkinson's disease through Parkin/Ambra1 signaling.
Zhou J; Zhao Y; Li Z; Zhu M; Wang Z; Li Y; Xu T; Feng D; Zhang S; Tang F; Yao J
Pharmacol Res; 2020 Oct; 160():105197. PubMed ID: 32942015
[TBL] [Abstract][Full Text] [Related]
5. Parkin protects against neurotoxicity in the 6-hydroxydopamine rat model for Parkinson's disease.
Vercammen L; Van der Perren A; Vaudano E; Gijsbers R; Debyser Z; Van den Haute C; Baekelandt V
Mol Ther; 2006 Nov; 14(5):716-23. PubMed ID: 16914382
[TBL] [Abstract][Full Text] [Related]
6. Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease.
Lehmensiek V; Tan EM; Liebau S; Lenk T; Zettlmeisl H; Schwarz J; Storch A
Neurochem Int; 2006 Apr; 48(5):329-40. PubMed ID: 16406146
[TBL] [Abstract][Full Text] [Related]
7. Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies.
Lopes FM; Schröder R; da Frota ML; Zanotto-Filho A; Müller CB; Pires AS; Meurer RT; Colpo GD; Gelain DP; Kapczinski F; Moreira JC; Fernandes Mda C; Klamt F
Brain Res; 2010 Jun; 1337():85-94. PubMed ID: 20380819
[TBL] [Abstract][Full Text] [Related]
8. PGAM5 regulates PINK1/Parkin-mediated mitophagy via DRP1 in CCCP-induced mitochondrial dysfunction.
Park YS; Choi SE; Koh HC
Toxicol Lett; 2018 Mar; 284():120-128. PubMed ID: 29241732
[TBL] [Abstract][Full Text] [Related]
9. RA Differentiation Enhances Dopaminergic Features, Changes Redox Parameters, and Increases Dopamine Transporter Dependency in 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells.
Lopes FM; da Motta LL; De Bastiani MA; Pfaffenseller B; Aguiar BW; de Souza LF; Zanatta G; Vargas DM; Schönhofen P; Londero GF; de Medeiros LM; Freire VN; Dafre AL; Castro MA; Parsons RB; Klamt F
Neurotox Res; 2017 May; 31(4):545-559. PubMed ID: 28155214
[TBL] [Abstract][Full Text] [Related]
10. Maackiain Ameliorates 6-Hydroxydopamine and
Tsai RT; Tsai CW; Liu SP; Gao JX; Kuo YH; Chao PM; Hung HS; Shyu WC; Lin SZ; Fu RH
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32585871
[TBL] [Abstract][Full Text] [Related]
11. Parkin loss of function contributes to RTP801 elevation and neurodegeneration in Parkinson's disease.
Romaní-Aumedes J; Canal M; Martín-Flores N; Sun X; Pérez-Fernández V; Wewering S; Fernández-Santiago R; Ezquerra M; Pont-Sunyer C; Lafuente A; Alberch J; Luebbert H; Tolosa E; Levy OA; Greene LA; Malagelada C
Cell Death Dis; 2014 Aug; 5(8):e1364. PubMed ID: 25101677
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial dysfunction induced by knockdown of mortalin is rescued by Parkin.
Yang H; Zhou X; Liu X; Yang L; Chen Q; Zhao D; Zuo J; Liu W
Biochem Biophys Res Commun; 2011 Jun; 410(1):114-20. PubMed ID: 21640711
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitin ligase HMG-CoA reductase degradation 1 (HRD1) prevents cell death in a cellular model of Parkinson's disease.
Omura T; Matsuda H; Nomura L; Imai S; Denda M; Nakagawa S; Yonezawa A; Nakagawa T; Yano I; Matsubara K
Biochem Biophys Res Commun; 2018 Nov; 506(3):516-521. PubMed ID: 30361093
[TBL] [Abstract][Full Text] [Related]
14. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
15. Alternative splicing generates different parkin protein isoforms: evidences in human, rat, and mouse brain.
Scuderi S; La Cognata V; Drago F; Cavallaro S; D'Agata V
Biomed Res Int; 2014; 2014():690796. PubMed ID: 25136611
[TBL] [Abstract][Full Text] [Related]
16. The Neuroprotective Role of Insulin Against MPP(+) -Induced Parkinson's Disease in Differentiated SH-SY5Y Cells.
Ramalingam M; Kim SJ
J Cell Biochem; 2016 Apr; 117(4):917-26. PubMed ID: 26364587
[TBL] [Abstract][Full Text] [Related]
17. Parkin maintains mitochondrial levels of the protective Parkinson's disease-related enzyme 17-β hydroxysteroid dehydrogenase type 10.
Bertolin G; Jacoupy M; Traver S; Ferrando-Miguel R; Saint Georges T; Grenier K; Ardila-Osorio H; Muriel MP; Takahashi H; Lees AJ; Gautier C; Guedin D; Coge F; Fon EA; Brice A; Corti O
Cell Death Differ; 2015 Oct; 22(10):1563-76. PubMed ID: 25591737
[TBL] [Abstract][Full Text] [Related]
18. Regulation of matrix metalloproteinase-9 gene expression in MPP+- or 6-OHDA-treated human neuroblastoma SK-N-BE(2)C cells.
Kim SY; Woo MS; Park JS; Kim HS
Neurochem Int; 2010 Feb; 56(3):437-42. PubMed ID: 19962414
[TBL] [Abstract][Full Text] [Related]
19. Increased vulnerability of parkin knock down PC12 cells to hydrogen peroxide toxicity: the role of salsolinol and NM-salsolinol.
Su Y; Duan J; Ying Z; Hou Y; Zhang Y; Wang R; Deng Y
Neuroscience; 2013 Mar; 233():72-85. PubMed ID: 23291452
[TBL] [Abstract][Full Text] [Related]
20. ATF4 protects against neuronal death in cellular Parkinson's disease models by maintaining levels of parkin.
Sun X; Liu J; Crary JF; Malagelada C; Sulzer D; Greene LA; Levy OA
J Neurosci; 2013 Feb; 33(6):2398-407. PubMed ID: 23392669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
